Spectrum Healthcare (UK) Ltd introduces the ErgoRaiser™

With its versatile range of elevations and angles of support, the unique ErgoRaiser™ can enable patients, including many with limited joint mobility and strength, to have their limb more comfortably supported in a raised position. This can help promote the musculoskeletal health and well-being of both patient and practitioner and...

Meet Millie, a bra you can help bring to market

Millie is a bra designed especially for women who have been through breast cancer treatment who want comfort and style. It's taken over a year to perfect the Millie prototype, and now they're ready to take millie to market, by pre-selling the bra on Kickstarter from Monday 27 February. Help...

Quotient Clinical expands into USA through acquisition of SeaView Research

Quotient Clinical (“Quotient”), the early phase drug development services provider, has announced that it has acquired SeaView Research (“SeaView”), expanding its operations into the USA. The acquisition combines Quotient and SeaView’s complementary customer portfolios, and strengthens the early phase clinical experience of the combined business, enabling the company to deliver...

Locate Therapeutics deepens development collaboration with Heraeus Medical GmbH

Nottingham based Locate Therapeutics (“Locate”) has announced the deepening of a development collaboration with the innovative orthopaedic company, Heraeus Medical GmbH. The new deal focuses on the use of Locate’s “state of the art” TAOS® (Targeted, Orchestrated Signaling) scaffold technology, in new areas of orthopaedic application. The Agreement follows the...

V Formation appoints new marketing specialist

Nottingham-based marketing consultancy, V Formation, has started the New Year with the recruitment of a new marketing consultant to its team, following a 40 percent increase in new client instructions during 2016. Experienced marketer, Jemma Taylor-Smith, joins V Formation as part of its strategic growth plans and will be supporting...

Co-Formulate strengthens relationship with Proveca to develop multiple paediatric formulations

Co-Formulate Limited (‘Co-Formulate’), a division of Quotient Clinical (‘Quotient’), a leading provider of early stage drug development services, has announced it has been contracted by Proveca Ltd. (Proveca) to perform paediatric formulation development work on several additional off-patent compounds. This agreement follows Co-Formulate’s successful development of an age-appropriate, taste-masked formulation...

Quotient’s CCO Simon Lee elected as Secretary of European CRO Federation

Quotient Clinical (“Quotient”), the innovative provider of early phase drug development services, is pleased to announce that Chief Compliance Officer, Simon Lee, has been elected as Secretary of the European CRO Federation (“EUCROF”). EUCROF is a non-profit organization that promotes clinical research and supports close relationships and the exchange of...

Your innovation deserves recognition

The Medilink Midlands Awards are now open, celebrating outstanding innovation across the region’s medtech and life sciences sector.

With 10 categories to enter, now’s the time to showcase your achievements.
Extended Deadline Date: 16th January

Start your application today.

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​